-15%

Collagen Peptides Type II joint-specific supplement for articular cartilage repair.

Collagen Peptides Type II | Joint-Specific Cartilage Support | $\geq$99% Purity

Name: Collagen Peptides Type II | Joint-Specific Cartilage Support | $geq$99% Purity - TITANFORGE LABS
Price: 55.00 USD
Availability: InStock

Original price was: $65.00.Current price is: $55.00.

Collagen Peptides Type II are the primary structural components of articular cartilage, making them the essential “scaffold” for joint health. Unlike Type I or III collagen found in skin and bone, Type II Collagen is specifically localized in the hyaline cartilage that cushions the joints. This specialized joint-specific booster provides high concentrations of hydroxyproline and glycine, which act as signaling molecules to trigger chondrocyte activity and the synthesis of the joint’s protective extracellular matrix

Categories: COLLAGEN & RECOVERY PEPTIDES, COLLAGEN PEPTIDE SUPPLEMENTS Tags: Arthritic Research, Bioactive Peptides, Cartilage Repair, Chondroprotective, Joint Health, Type II Collagen

Description

Collagen Peptides Type II: The Structural Foundation of Articular Integrity

The Bio-Specificity of Type II Collagen

In the hierarchy of structural proteins, Type II Collagen is unique. It consists of three identical alpha-1 (II) chains that form a tight triple helix, providing the tensile strength necessary for cartilage to resist shearing forces and high-impact mechanical stress. While Type I collagen forms thick, rigid fibers, Collagen Peptides Type II create a loose, flexible network that allows the joint to remain hydrated and resilient under pressure.

Mechanism of Action: Chondroprotection and ECM Renewal

Research into Collagen Peptides Type II focuses on its dual-action role in the musculoskeletal system:

Stimulation of Chondrocytes: These peptides act as ligands that bind to receptors on chondrocytes (cartilage cells), signaling them to increase the production of new Type II fibers and proteoglycans like Aggrecan.
Immune-Mediated Oral Tolerance: In its undenatured form, Type II Collagen is studied for its ability to “train” the immune system (via Peyer’s patches in the gut) to stop attacking joint tissue, potentially mitigating inflammatory responses in degenerative joint conditions.
Synovial Fluid Viscosity: By providing the raw materials for Hyaluronic Acid production, these peptides help maintain the lubricating properties of the synovial fluid, reducing friction and wear-and-tear.

[Image showing the triple-helix structure of Type II collagen vs Type I]

Why Choose Joint-Specific Type II Over General Collagen?

Targeted Delivery: While the body can utilize any amino acids, Collagen Peptides Type II contain the specific peptide sequences that have the highest affinity for cartilage tissue.
Superior Bioavailability: Our hydrolyzed Type II peptides are broken down to a molecular weight of <2000 Daltons, ensuring rapid absorption and direct transport to the joint capsule.
Matrix Integrity: Specifically addresses the “wear-and-tear” of the intervertebral discs and the vitreous humor, areas where Type I collagen is largely ineffective.

4. Technical Specifications (E-E-A-T Data)

Feature	Scientific Specification
Source Material	Sternal Cartilage (Bovine/Avian)
Active Molecule	Hydrolyzed Type II Alpha-1 Chains
Molecular Weight	1,500 – 2,500 Da (Ultra-Low for Joints)
Purity Grade	$\geq$ 99% as determined by SDS-PAGE
Protein Content	$\geq$ 90% Bioactive Peptides
Amino Acid Profile	Rich in Hydroxylysine and Hydroxyproline

5. Product FAQ

Q: How do Collagen Peptides Type II differ from Type I/III?

A: Type I and III are predominantly for skin, bone, and tendons. Collagen Peptides Type II are the only type found in articular cartilage. If the research goal is joint mobility or cartilage regeneration, Type II is the necessary scientific standard.

Q: Can Type II Collagen be used for recovery from sports injuries?

A: Yes. In research models, Type II Collagen has been shown to accelerate the repair of the extracellular matrix following mechanical load or injury, specifically by inhibiting the release of TNF-α and IL-6, which are markers of joint inflammation.